These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15504769)

  • 1. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
    Agrawal S; Saluja I; Kaczorowski J
    Acad Med; 2004 Nov; 79(11):1046-50. PubMed ID: 15504769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What residents don't know about physician-pharmaceutical industry interactions.
    Watkins RS; Kimberly J
    Acad Med; 2004 May; 79(5):432-7. PubMed ID: 15107282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
    Hopper JA; Speece MW; Musial JL
    J Gen Intern Med; 1997 Oct; 12(10):639-42. PubMed ID: 9346461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula.
    Weißkircher J; Koch C; Dreimüller N; Lieb K
    GMS J Med Educ; 2017; 34(3):Doc37. PubMed ID: 28890928
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study.
    Kao AC; Braddock C; Clay M; Elliott D; Epstein SK; Filstead W; Hotze T; May W; Reenan J
    Acad Med; 2011 Nov; 86(11):1454-62. PubMed ID: 21952057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.
    McKinney WP; Schiedermayer DL; Lurie N; Simpson DE; Goodman JL; Rich EC
    JAMA; 1990 Oct; 264(13):1693-7. PubMed ID: 2398609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
    Steinman MA; Shlipak MG; McPhee SJ
    Am J Med; 2001 May; 110(7):551-7. PubMed ID: 11347622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
    Randall ML; Rosenbaum JR; Rohrbaugh RM; Rosenheck RA
    Acad Psychiatry; 2005; 29(1):33-9. PubMed ID: 15772402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teaching information mastery: evaluating information provided by pharmaceutical representatives.
    Shaughnessy AF; Slawson DC; Bennett JH
    Fam Med; 1995 Oct; 27(9):581-5. PubMed ID: 8829983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Need for better interactions between physicians and pharmaceutical sales representatives.
    Ferguson RP
    Ann Pharmacother; 2002 Dec; 36(12):1966-8. PubMed ID: 12494952
    [No Abstract]   [Full Text] [Related]  

  • 19. Why lunch matters: assessing physicians' perceptions about industry relationships.
    Fugh-Berman AJ; Scialli AR; Bell AM
    J Contin Educ Health Prof; 2010; 30(3):197-204. PubMed ID: 20872775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry interactions in family medicine residencies decreased between 2008 and 2013: a CERA study.
    Brown SR; Evans DV; Fugh-Berman A
    Fam Med; 2015 Apr; 47(4):279-82. PubMed ID: 25853598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.